Marwan Sabbagh

2.2k total citations · 1 hit paper
13 papers, 927 citations indexed

About

Marwan Sabbagh is a scholar working on Physiology, Molecular Biology and Pharmacology. According to data from OpenAlex, Marwan Sabbagh has authored 13 papers receiving a total of 927 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Physiology, 6 papers in Molecular Biology and 3 papers in Pharmacology. Recurrent topics in Marwan Sabbagh's work include Alzheimer's disease research and treatments (7 papers), Cholinesterase and Neurodegenerative Diseases (3 papers) and Prion Diseases and Protein Misfolding (2 papers). Marwan Sabbagh is often cited by papers focused on Alzheimer's disease research and treatments (7 papers), Cholinesterase and Neurodegenerative Diseases (3 papers) and Prion Diseases and Protein Misfolding (2 papers). Marwan Sabbagh collaborates with scholars based in United States, France and Spain. Marwan Sabbagh's co-authors include Jeffrey L. Cummings, Agneta Nordberg, Stephen Salloway, Kaj Blennow, Stefano F. Cappa, Stéphane Epelbaum, Christopher C. Rowe, Marc Teichmann, Howard Feldman and Stéphanie Bombois and has published in prestigious journals such as Neurology, The Lancet Neurology and Movement Disorders.

In The Last Decade

Marwan Sabbagh

13 papers receiving 913 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group

2021 598 citations Bruno Dubois, Nicolas Villain et al. The Lancet Neurology profile →

Peers

Marwan Sabbagh

PHYSI

PMH

MB

NEURO

Cuibai Wei China

Ashvini Keshavan United Kingdom

Kerstin Heurling Sweden

Eric B. Larson United States

Lucrezia Hausner Germany

Manu Vandijck Belgium

Wagner S. Brum Brazil

Robert Rusina Czechia

Brendan Kelley United States

Dantao Peng China

Cuibai Wei China

Marwan Sabbagh

387 ×0.9

PHYSI

421 ×1.2

PMH

396 ×1.8

MB

238 ×1.5

NEURO

86 ×0.7

NEURO

Citations per year, relative to Marwan Sabbagh Marwan Sabbagh (= 1×) peers Cuibai Wei

Countries citing papers authored by Marwan Sabbagh

Since Specialization

Citations

This map shows the geographic impact of Marwan Sabbagh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marwan Sabbagh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marwan Sabbagh more than expected).

Fields of papers citing papers by Marwan Sabbagh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marwan Sabbagh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marwan Sabbagh. The network helps show where Marwan Sabbagh may publish in the future.

Co-authorship network of co-authors of Marwan Sabbagh

This figure shows the co-authorship network connecting the top 25 collaborators of Marwan Sabbagh. A scholar is included among the top collaborators of Marwan Sabbagh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marwan Sabbagh. Marwan Sabbagh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Feldman, Howard, Karen Messer, Yuqi Qiu, et al.. (2024). Varoglutamstat: Inhibiting Glutaminyl Cyclase as a Novel Target of Therapy in Early Alzheimer’s Disease. Journal of Alzheimer s Disease. 101(s1). S79–S93. 5 indexed citations

2.

Sabbagh, Marwan, Cristina Boschini, Sharon Cohen, et al.. (2023). Safety profile of semaglutide in people aged 55 years and over: pooled data from the PIONEER, SUSTAIN and STEP phase 3 clinical programmes. Alzheimer s & Dementia. 19(S21). 2 indexed citations

3.

Abushakra, Susan, Jerome Barakos, Philip Scheltens, et al.. (2023). Prevalence of Amyloid-Related Imaging Abnormalities in APOE4/4 Homozygotes with Early Alzheimer’s Disease: Baseline Findings from Ongoing Clinical Trials of Oral Anti-Amyloid Agent ALZ-801 (Valiltramiprosate) (P5-6.003). Neurology. 100(17_supplement_2). 2 indexed citations

4.

Delrieu, Julien, Randall J. Bateman, J. Touchon, Marwan Sabbagh, & Jeffrey L. Cummings. (2022). The Future of AD Clinical Trials with the Advent of Anti-Amyloid Therapies: An CTAD Task Force Report. The Journal of Prevention of Alzheimer s Disease. 9(3). 393–399. 15 indexed citations

5.

Raman, Rema, Paul Aisen, Joshua D. Grill, et al.. (2022). Tackling a Major Deficiency of Diversity in Alzheimer's Disease Therapeutic Trials: An CTAD Task Force Report. The Journal of Prevention of Alzheimer s Disease. 9(3). 388–392. 31 indexed citations

6.

Dubois, Bruno, Nicolas Villain, Giovanni B. Frisoni, et al.. (2021). Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group. The Lancet Neurology. 20(6). 484–496. 598 indexed citations breakdown →

7.

Roher, Alex E., Tyler A. Kokjohn, Steven Clarke, et al.. (2017). APP/Aβ structural diversity and Alzheimer's disease pathogenesis. Neurochemistry International. 110. 1–13. 80 indexed citations

8.

Roher, Alex E., Chera L. Maarouf, Tyler A. Kokjohn, et al.. (2016). Chemical and neuropathological analyses of an Alzheimer's disease patient treated with solanezumab.. PubMed Central. 5(4). 158–170. 12 indexed citations

9.

Hamlett, Eric D., Edward J. Goetzl, Aurélie Ledreux, et al.. (2016). Neuronal exosomes reveal Alzheimer's disease biomarkers in Down syndrome. Alzheimer s & Dementia. 13(5). 541–549. 95 indexed citations

10.

Shill, Holly A., et al.. (2013). Aquatic Therapy and Alzheimer's Disease. 3 indexed citations

11.

Evidente, Virgilio Gerald H., Erika Driver‐Dunckley, Joseph G. Hentz, et al.. (2010). Olfaction in the Elderly: A Cross-Sectional Analysis Comparing Parkinson's Disease with Controls and Other Disorders. International Journal of Neuroscience. 120(1). 36–39. 40 indexed citations

12.

Siegel, Andrew M., Winnie S. Liang, John V. Pearson, et al.. (2008). Neuronal gene expression correlates of Parkinson's disease with dementia. Movement Disorders. 23(11). 1588–1595. 43 indexed citations

13.

Sabbagh, Marwan. (2008). Frequently Asked Questions About Alzheimer's. Clinical Psychiatry News. 36(9). 12–12. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact